These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24286159)

  • 1. Predicting type 2 diabetes mellitus using haemoglobin A1c: a community-based historic cohort study.
    Lerner N; Shani M; Vinker S
    Eur J Gen Pract; 2014 Jun; 20(2):100-6. PubMed ID: 24286159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with glycated hemoglobin A1c trajectories progressing to type 2 diabetes.
    Halalau A; Roy S; Hegde A; Khanal S; Langnas E; Raja M; Homayouni R
    Ann Med; 2023 Dec; 55(1):371-378. PubMed ID: 36621941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Svensson AM; Gudbjörnsdóttir S; Eliasson B
    J Intern Med; 2010 Nov; 268(5):471-82. PubMed ID: 20804517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect modification in the association between glycated haemoglobin and cardiovascular disease and mortality in patients with type 2 diabetes.
    van Munster SN; van der Graaf Y; de Valk HW; Visseren FL; Westerink J;
    Diabetes Obes Metab; 2017 Mar; 19(3):320-328. PubMed ID: 27807924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.
    Raghavan S; Vassy JL; Ho YL; Song RJ; Gagnon DR; Cho K; Wilson PWF; Phillips LS
    J Am Heart Assoc; 2019 Feb; 8(4):e011295. PubMed ID: 30776949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
    Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
    J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of hemoglobin A1c in predicting diabetes risk.
    Edelman D; Olsen MK; Dudley TK; Harris AC; Oddone EZ
    J Gen Intern Med; 2004 Dec; 19(12):1175-80. PubMed ID: 15610327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between HbA
    Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
    Diabetes Metab; 2018 Nov; 44(5):415-423. PubMed ID: 29449147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of type 2 diabetes in pre-diabetic Japanese individuals categorized by HbA1c levels: a historical cohort study.
    Kawahara T; Imawatari R; Kawahara C; Inazu T; Suzuki G
    PLoS One; 2015; 10(4):e0122698. PubMed ID: 25853519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Leite NC; Ferreira MT; Salles GF
    Acta Diabetol; 2015 Feb; 52(1):21-9. PubMed ID: 24816865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-pregnancy dysglycemia in obese pregnancies after negative testing for gestational diabetes and risk of future childhood overweight: An interim analysis from a longitudinal mother-child cohort study.
    Gomes D; von Kries R; Delius M; Mansmann U; Nast M; Stubert M; Langhammer L; Haas NA; Netz H; Obermeier V; Kuhle S; Holdt LM; Teupser D; Hasbargen U; Roscher AA; Ensenauer R
    PLoS Med; 2018 Oct; 15(10):e1002681. PubMed ID: 30372451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes.
    Orsi E; Solini A; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Gruden G; Morano S; Nicolucci A; Penno G; Pugliese G;
    Diabetes Obes Metab; 2018 Aug; 20(8):1885-1893. PubMed ID: 29582548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10- year cohort study.
    Wan EYF; Yu EYT; Chin WY; Ng FTY; Chia SMC; Wong ICK; Chan EWY; Lam CLK
    Diabetes Obes Metab; 2020 Aug; 22(8):1316-1327. PubMed ID: 32196917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visit-to-Visit HbA
    Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
    Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship between Red Blood Cell Distribution Width and Incident Diabetes in Chinese Adults: A Cohort Study.
    Wang J; Zhang Y; Wan Y; Fan Z; Xu R
    J Diabetes Res; 2020; 2020():1623247. PubMed ID: 32185232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up.
    Tillmann FP; Schmitz M; Rump LC; Quack I
    Int Urol Nephrol; 2018 Apr; 50(4):771-777. PubMed ID: 29197933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of haemoglobin A1c to detect impaired fasting glucose or Type 2 diabetes in a United Kingdom community based population.
    Kumaravel B; Bachmann MO; Murray N; Dhatariya K; Fenech M; John WG; Scarpello TJ; Sampson MJ;
    Diabetes Res Clin Pract; 2012 May; 96(2):211-6. PubMed ID: 22257419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study.
    Wan EY; Yu EY; Chen JY; Wong IC; Chan EW; Lam CL
    Diabetes Obes Metab; 2020 Dec; 22(12):2325-2334. PubMed ID: 32744402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct trajectories in HbA1c are associated with different all-cause mortality and morbidity in newly diagnosed patients with type 2 diabetes.
    Hemo B; Geva D; Shahar DR; Golan R; Heymann AD
    Prim Care Diabetes; 2020 Oct; 14(5):413-419. PubMed ID: 31836307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fasting plasma glucose and haemoglobin A1c point-of-care tests in screening for diabetes and abnormal glucose regulation in a rural low income setting.
    Mayega RW; Guwatudde D; Makumbi FE; Nakwagala FN; Peterson S; Tomson G; Ostenson CG
    Diabetes Res Clin Pract; 2014 Apr; 104(1):112-20. PubMed ID: 24456993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.